Protecting Texas Medicaid Program from Unlawful Federal Changes

Translate to Spanish or other 102 languages!

The lawsuit argues that the imposed requirements are neither supported by existing laws nor mandated by current regulations. Image for illustration purposes
The lawsuit argues that the imposed requirements are neither supported by existing laws nor mandated by current regulations. Image for illustration purposes

Mega Doctor News

- Advertisement -

AUSTIN – Texas Attorney General Paxton has launched a legal battle against the Centers for Medicare and Medicaid Services (CMS) and the U.S. Department of Health and Human Services (HHS), contesting a federal bulletin that poses a threat to Texas’s Medicaid program and its nearly five million beneficiaries. 

The lawsuit argues that the imposed requirements are neither supported by existing laws nor mandated by current regulations. Furthermore, Attorney General Paxton has filed a motion for a preliminary injunction to halt CMS’s actions.

Attorney General Paxton expressed concerns that CMS’s actions could jeopardize not only local governments’ ability to support Medicaid providers but also the entire state’s capacity to fund its Medicaid program. The potential consequences of CMS’s actions could lead to reduced access to healthcare for vulnerable Texans and hinder local providers’ ability to serve communities across the state.

- Advertisement -

Texas’s Medicaid program relies on funding from both the state and federal government, with local governments also contributing to ensure access to healthcare for citizens, irrespective of income level. Since 2013, and with CMS’s authorization, Texas has permitted local governments to administer Local Provider Participation Funds (LPPFs). In 2021, the Biden administration’s CMS attempted to revoke Texas Medicaid’s use of LPPFs, but a preliminary injunction was issued against this effort.

LPPFs involve local governments collecting mandatory assessments from healthcare providers and transferring these funds to the state to finance Texas’s share of non-federal Medicaid funding. Federal law explicitly allows such arrangements. However, federal law also prohibits hold harmless arrangements, which guarantee healthcare providers will receive their total tax payment back through Medicaid payments. CMS recently issued an unlawful informational bulletin that would wrongly classify private contracts involving entities that contribute to an LPPF as prohibited hold harmless arrangements, even though federal law does not prohibit such private contracts.

CMS’s bulletin revealed its intent to require the Texas Health and Human Services Commission (HHSC) to provide information about these private “hold harmless arrangements” as a prerequisite for receiving federal funding, despite the HHSC’s lack of authority to do so. This could potentially endanger billions of dollars meant for Texas’s Medicaid program. The changes represent a significant departure from CMS’s previous policy and an unprecedented expansion of its authority.

To read the full complaint, click here.  

- Advertisement -

To read the motion for preliminary injunction, click here

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

What to Know About the Cyclospora Parasite in Your Grocery Cart

You’ve probably seen the headlines about a parasite spreading across the United States and making people sick, but what exactly is causing it? 

STHS Children’s Free Food Safety Webinar for Parents on July 15th

Every meal should help children grow and thrive, not put their health at risk.

How Extreme Weather and Air Pollution Put Your Heart at Risk

It’s not just high temperatures that can put stress on the heart. Other environmental factors, such as air pollution, extreme cold, hurricanes, wildfires, and other climate events, can contribute to or worsen cardiovascular conditions.

Scientists Unlock Faster, Better Way to Capture Ultimate Cancer-Fighting Cells

A new platform developed by researchers at The University of Texas MD Anderson Cancer Center quickly finds and isolates rare, tumor-reactive immune cells that are especially good at recognizing and attacking cancer cells, even without knowing which tumor targets are recognized by the immune cells. This approach addresses a major bottleneck in immunotherapy development and could potentially accelerate the creation of personalized treatments.
- Advertisement -